Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Revelation Biosciences Inc REVBW


Primary Symbol: REVB

Healthcare Biotechnology
Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and... see more

Current News (NDAQ:REVB)

Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting

ACCESS Newswire 10 days ago

Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year

ACCESS Newswire November 20, 2025

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025

ACCESS Newswire November 6, 2025

Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date

ACCESS Newswire October 29, 2025

Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025

ACCESS Newswire October 15, 2025

Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds

ACCESS Newswire September 11, 2025

Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data

ACCESS Newswire September 10, 2025

Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data

ACCESS Newswire September 9, 2025

Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study

ACCESS Newswire September 9, 2025
View More News ››

Opinion & Analysis (NDAQ:REVB)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:REVB)

REVB....$1.46

LMFBO
Iseneschal - September 25, 2025

REVB....on 2nd thought...save ur money

I can tell the way The Maggot trades this.....he's Maddapakka witha capital M No more Devil Stock!!!!!!
Iseneschal - September 24, 2025

REVB.....Been in a downtrend for a while...Now at $1.53

As much as I f'king dispise this pile of escrement......I bot a small position sub $1.50 Might add on weakness The reason I hate...
Iseneschal - September 24, 2025

REVB.....Share price is above VWAP on most parameters

The 1 min .....the 5 min.....the 1 hr.....the 2 hr......the 4 hr and the daily Share Price at $1.65..... just an observation
Iseneschal - September 16, 2025

REVB....Mr. M is getting jiggy with it ; )

Traded over $1.70
Iseneschal - September 16, 2025

RE:REVB....N.L.O.D $1.53 ...which is also All time low

No guarantees but it is a possibility.....You could wake up tomorrow and it's trading at $5
Iseneschal - September 15, 2025
View more Bullboard ››

dynaCERT Inc.

dynaCERT Inc.

dynaCERT Inc., together with its subsidiaries, engages in the design, engineering, manufacture, testing, and distribution of ...
View More »